Cite
HARVARD Citation
Marinelli, B. et al. (2022). Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study. Journal for immunotherapy of cancer. 10 (6), p. . [Online].